| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_241c3d4e236532a2e822eb39f56b1be9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 |
| filingDate |
2021-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19ec6a294a43c5c47946388e53eca96e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e805e76ea3a506067ab9bab55d66ab0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7685ad1be13625ba0eacfa8f131a9f16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c7cf2b38ea7294bda5107e28bb032f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab91811aa978697ed0b72340343a4110
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4010c2faa753e6083c8eb0f706fcfac9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a344075e18717d256bed8ac88f90a1a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2b7c5864b68ec35a37fa460c14464d4 |
| publicationDate |
2021-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2021075534-A |
| titleOfInvention |
Aqueous eye drops |
| abstract |
PROBLEM TO BE SOLVED: To provide a diquafosol ophthalmic solution containing no benzalkonium chloride and having higher safety. Further, a diquafosol ophthalmic solution containing a preservative that is physicochemically stable even during preparation of ophthalmic solution and long-term storage is provided. An aqueous ophthalmic solution containing diquafosol or a salt thereof at a concentration of 0.1 to 10% (w / v) and chlorhexidines at a concentration of 0.0001 to 0.1% (w / v). .. [Selection diagram] None |
| priorityDate |
2015-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |